Home›Stock Screener›Fredun Pharmaceuticals›P/E Ratio

Fredun Pharmaceuticals P/E Ratio

Current P/E Ratio
52.37
High Valuation
Very High - High growth expectations or significantly overvalued

Fredun Pharmaceuticals P/E ratio. Fredun Pharmaceuticals (FREDUN) P/E ratio is 52.37 (High), EPS (TTM) ₹66.81, current price ₹1363.20 on NSE vs historical average P/E of 22.8 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Also explore FREDUN stock price history to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 52.37
Current Price ₹1363.20
EPS (TTM) ₹66.81
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 22.8
Historical Range 22.8 - 22.8
Percentile 100.0%

Sector Context

Sector Average 56.21
Sector Median 32.41
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹76.21
Mar 2026 ₹19.70
Jun 2026 ₹23.82

FREDUN P/E Ratio — Valuation Signal & Historical Context

Fredun Pharmaceuticals P/E 52.37 vs historical average 22.8, range 22.8–22.8 — signal: Overvalued. Examine FREDUN quarterly results for recent quarterly revenue, profit and EPS trends.

  • Stock appears overvalued with PE of 52.37, suggesting caution for new investments
  • Current PE is 129.7% above historical average

Fredun Pharmaceuticals P/E Ratio Historical Trend

FREDUN annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 52.37 vs historical average 22.8. For live price, revenue and the complete fundamental profile, see FREDUN share price.

FREDUN Historical P/E Ratio — EPS, Year-End Price & Valuation

Fredun Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 22.8 69.21 ₹1578.30 BSE Moderate

FREDUN vs Healthcare Peers — P/E Ratio Comparison

Fredun Pharmaceuticals P/E 52.37 vs Healthcare average 56.21, median 32.41 — range 2.04–740.29.

Sector Average
56.21
Sector Median
32.41
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low